Evidence map›Paper›PMID 42715298›Full record

ArticleScience advances2026

Substrate heterogeneity promotes cancer cell dissemination through interface roughening.

Zuzana Dunajová, Saren Tasciyan, Juraj Májek, Jack Merrin, Robert P Jenkins, Erik Sahai, Michael Sixt, Edouard Hannezo

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zuzana DunajováInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0000-0003-4827-912X
Saren TasciyanInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0000-0003-1671-393X
Juraj MájekInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0009-0005-6251-9814
Jack MerrinInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0000-0001-5145-4609
Robert P JenkinsTumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-6186-7746
Erik SahaiTumour Cell Biology Laboratory, The Francis Crick Institute, London, UK.ORCID 0000-0002-3932-5086
Michael SixtInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0000-0002-6620-9179
Edouard HannezoInstitute of Science and Technology Austria (IST Austria), am Campus 1, 3400 Klosterneuburg, Austria.ORCID 0000-0001-6005-1561

Funding

Wellcome Trust CC2040
6 · The paper itself

Abstract

Although studies of tumor invasion have mainly emphasized the evolution of genetic and epigenetic heterogeneity, cellular behaviors also depend on the physical microenvironment. Yet, the tumor microenvironment is both complex and continuously remodeled, making it hard to rigorously test its causal influence on tumor dissemination. Here, we adopted a reductionist approach to studying tumor cell invasion in microengineered environments of tunable patterned geometries. We find that not only the presence of obstacles but more unexpectedly their spatial disorder causes a drastic shift from a collective to a single-cell mode of invasion-comparable in strength to loss of cell-cell adhesion. Combining live-imaging and perturbation experiments with minimal biophysical modeling, we demonstrate that cell dissemination results both from local geometrical constraints and a global integration of spatial disorder over time. We identify generic universality classes of invasion dynamics dependent on environmental geometry, enabling us to identify quantitative physical principles for tumor dissemination.

Indexed as

NeoplasmsTumor MicroenvironmentAnimalsCell AdhesionCell Line, TumorCell MovementHumansModels, BiologicalNeoplasm Invasiveness

Identifiers

PMID42715298
PMCPMC13557091

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.